Skip to main content
FeaturedNews

CSL Behring Recognized Kankakee Site Honored as “Employer of the Year”

CSL Behring Recognized Kankakee Site Honored as “Employer of the Year”

Don Konemann II (center) accepted the honor on behalf of CSL Behring’s Kankakee site. Maureen Powell, Site head of Communications, (second from right) also attended the ceremony. They are pictured with representatives from the Illinois Department of Employment Security and the American Legion.

 

KANKAKEE, Ill. – July 18, 2017 — CSL Behring’s Kankakee facility recently was recognized as “Employer of the Year” by the American Legion Department of Illinois. The award was in recognition of distinguished cooperation with the American Legion Economic Commission in the promotion of a program for training, counseling and employment of U.S. military veterans. Accepting the award on behalf of CSL Behring was Don Konemann II, Director and BT Site Head, is also a U.S. Navy veteran.

Don said, “At CSL Behring, we are driven by our promise of saving lives. Our mission is much the same as veterans who respond in extraordinary ways to protect our nation. We are truly honored to accept this award.”

About 12 percent of the workforce at Kankakee site is made up of veterans. The facility has an Annual Salute to Service Ceremony, where it recognizes and honors employees who have served in the U.S. military. Plaques and photos of our employee veterans are prominently displayed on the site’s Salute to Service wall.

The award was presented at the 99th Annual Department of Illinois Convention in Springfield, Illinois on July 14, 2017.

 

About CSL Behring

CSL Behring is a global biotherapeutics leader driven by its promise to save lives. Focused on serving patients’ needs by using the latest technologies, we develop and deliver innovative therapies that are used to treat coagulation disorders, primary immune deficiencies, hereditary angioedema, inherited respiratory disease, and neurological disorders. The company’s products are also used in cardiac surgery, organ transplantation, burn treatment and to prevent hemolytic disease of the newborn.

X